[Federal Register Volume 63, Number 170 (Wednesday, September 2, 1998)]
[Rules and Regulations]
[Page 46652]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-23583]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 522


Implantation or Injectable Dosage Form New Animal Drugs; 
Ampicillin Trihydrate For Sterile Suspension; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of August 4, 1998 (63 FR 
41419). The document amended the animal drug regulations to reflect 
approval of an abbreviated new animal drug application (ANADA) filed by 
G. C. Hanford Manufacturing Co. The document published with an 
incorrect address. This document corrects that error.

EFFECTIVE DATE: September 2, 1998.
FOR FURTHER INFORMATION CONTACT: Carolyn C. Harris, Office of Policy 
(HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
20857, 301-443-2994.

SUPPLEMENTARY INFORMATION: In FR Doc. 98-20698, appearing on page 
41419, in the Federal Register of August 4, 1998, the following 
correction is made: On page 41420, in the first column, in the first 
complete paragraph, beginning in the ninth line, ``12420 Parklawn Dr., 
rm. 1-23, Rockville, MD 20857'' is corrected to read ``5630 Fishers 
Lane, rm. 1061, Rockville, MD 20852''.

    Dated: August 26, 1998.
 William K. Hubbard,
 Associate Commissioner for Policy Coordination.
[FR Doc. 98-23583 Filed 9-1-98; 8:45 am]
BILLING CODE 4160-01-F